ClinicalTrials.govpublic full text
Phase 2 Study of Belimumab Administered Subcutaneously to Subjects With Systemic Lupus Erythematosus (SLE)
systemic lupus erythematosus, sle, lupus, antibodies, autoimmune diseases, belimumab, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 833848
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.